» Articles » PMID: 32821288

Reduction in the Procedure Time of Hybrid Endoscopic Submucosal Dissection for Early Gastric Neoplasms: a Multi-center Retrospective Propensity Score-matched Analysis

Overview
Publisher Sage Publications
Specialty Gastroenterology
Date 2020 Aug 22
PMID 32821288
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endoscopic submucosal dissection (ESD) for early gastric neoplasms is still a technically difficult and time-consuming procedure. Hybrid ESD (H-ESD) involves circumferential incision with partial submucosal dissection combined with subsequent mucosal resection by snaring, wherein the newly developed device allows us to perform H-ESD using a single device. This study aimed to determine the clinical outcomes of H-ESD compared with conventional ESD (C-ESD) for early gastric neoplasms.

Methods: In this multi-center, retrospective study, using propensity score-matched analysis, we reviewed the charts of patients with early gastric neoplasms smaller than 20 mm treated with H-ESD or C-ESD at three hospitals between January 2017 and October 2018. The primary outcome was the procedure time, and the secondary outcomes were other factors, including the en bloc resection rate, complete resection rate, curative resection rate, and rate of adverse events.

Results: Among 215 patients, 29 underwent H-ESD and 186 underwent C-ESD; 29 pairs were created by propensity score matching. In the H-ESD group, 82.8% of lesions met the absolute indication [mucosal lesions limited to 20-mm diameter, dominated by differentiated adenocarcinoma without ulcer (scar)] for endoscopic resection (ER). As a result, the procedure time of H-ESD was significantly shorter than that of C-ESD [20 (interquartile range, 12-27) min 40 (30-50) min;  < 0.001]. There was no significant difference in the secondary outcomes between the two groups.

Conclusion: H-ESD contributed to reduced procedure time. Therefore, H-ESD could be an alternative endoscopic treatment for gastric neoplasms when the lesion fulfils the absolute indication for ER.

Citing Articles

Comparison of the procedure time differences between hybrid endoscopic submucosal dissection and conventional endoscopic submucosal dissection in patients with early gastric neoplasms: a study protocol for a multi-center randomized controlled trial....

Esaki M, Ihara E, Fujii H, Sumida Y, Haraguchi K, Takahashi S Trials. 2022; 23(1):166.

PMID: 35189939 PMC: 8862302. DOI: 10.1186/s13063-022-06099-x.


Efficacy of hybrid endoscopic submucosal dissection with SOUTEN in gastric lesions: An porcine model basic study.

Esaki M, Ihara E, Hashimoto N, Abe S, Aratono C, Shiga N World J Gastrointest Surg. 2021; 13(6):563-573.

PMID: 34194614 PMC: 8223703. DOI: 10.4240/wjgs.v13.i6.563.

References
1.
Kim S, Choi C, Kang D, Kim H, Park S, Nam H . Endoscopic submucosal dissection of gastric neoplasms using a snare tip. Scand J Gastroenterol. 2017; 53(2):238-242. DOI: 10.1080/00365521.2017.1410567. View

2.
Kim J, Nam H, Choi C, Kang D, Kim H, Park S . Risk factors associated with difficult gastric endoscopic submucosal dissection: predicting difficult ESD. Surg Endosc. 2016; 31(4):1617-1626. DOI: 10.1007/s00464-016-5149-6. View

3.
Austin P . Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009; 28(25):3083-107. PMC: 3472075. DOI: 10.1002/sim.3697. View

4.
Bae J, Yang D, Lee S, Soh J, Lee S, Lee H . Optimized hybrid endoscopic submucosal dissection for colorectal tumors: a randomized controlled trial. Gastrointest Endosc. 2015; 83(3):584-92. DOI: 10.1016/j.gie.2015.06.057. View

5.
Park S, Kim J, Ji J, Choi H, Lee B, Kim B . Efficacy of endoscopic mucosal resections for the management of small gastric adenomas with low-grade dysplasia. Scand J Gastroenterol. 2015; 50(9):1175-82. DOI: 10.3109/00365521.2015.1045023. View